AngioDynamics, Inc. (ANGO): Price and Financial Metrics


AngioDynamics, Inc. (ANGO): $24.31

0.01 (+0.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ANGO POWR Grades


  • Growth is the dimension where ANGO ranks best; there it ranks ahead of 71.88% of US stocks.
  • The strongest trend for ANGO is in Sentiment, which has been heading down over the past 179 days.
  • ANGO's current lowest rank is in the Quality metric (where it is better than 19.29% of US stocks).

ANGO Stock Summary

  • Price to trailing twelve month operating cash flow for ANGO is currently 75.71, higher than 93.39% of US stocks with positive operating cash flow.
  • For ANGO, its debt to operating expenses ratio is greater than that reported by merely 15.69% of US equities we're observing.
  • With a year-over-year growth in debt of -37.5%, Angiodynamics Inc's debt growth rate surpasses only 10.8% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Angiodynamics Inc are LFUS, KERN, PIXY, CSPI, and CARS.
  • ANGO's SEC filings can be seen here. And to visit Angiodynamics Inc's official web site, go to www.angiodynamics.com.

ANGO Valuation Summary

  • ANGO's EV/EBIT ratio is -30.1; this is 202.73% lower than that of the median Healthcare stock.
  • Over the past 210 months, ANGO's price/earnings ratio has gone down 105.7.
  • Over the past 210 months, ANGO's EV/EBIT ratio has gone down 69.7.

Below are key valuation metrics over time for ANGO.

Stock Date P/S P/B P/E EV/EBIT
ANGO 2021-08-31 3.7 2.5 -34.5 -30.1
ANGO 2021-08-30 3.8 2.5 -34.7 -30.3
ANGO 2021-08-27 3.7 2.5 -34.4 -30.0
ANGO 2021-08-26 3.6 2.4 -33.6 -29.3
ANGO 2021-08-25 3.7 2.4 -33.7 -29.4
ANGO 2021-08-24 3.7 2.4 -34.0 -29.7

ANGO Growth Metrics

    The 3 year net income to common stockholders growth rate now stands at 450.65%.
  • The 2 year net cashflow from operations growth rate now stands at -81.98%.
  • Its 4 year net income to common stockholders growth rate is now at 3872.29%.
Over the past 34 months, ANGO's revenue has gone down $48,226,000.

The table below shows ANGO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 303.275 11.107 -38.335
2021-09-30 297.765 20.614 -34.252
2021-06-30 291.01 24.093 -31.548
2021-03-31 272.5 15.774 -169.147
2020-12-31 271.098 -7.934 -171.312
2020-09-30 268.331 -13.445 -169.78

ANGO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANGO has a Quality Grade of D, ranking ahead of 15.86% of graded US stocks.
  • ANGO's asset turnover comes in at 0.521 -- ranking 88th of 186 Medical Equipment stocks.
  • CLPT, EW, and IVC are the stocks whose asset turnover ratios are most correlated with ANGO.

The table below shows ANGO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-08-31 0.521 0.541 -0.324
2021-05-31 0.503 0.539 -0.282
2021-02-28 0.464 0.531 -1.297
2020-11-30 0.434 0.540 -1.344
2020-08-31 0.407 0.551 -1.516
2020-05-31 0.385 0.569 -1.758

ANGO Price Target

For more insight on analysts targets of ANGO, see our ANGO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.00 Average Broker Recommendation 1.5 (Moderate Buy)

ANGO Stock Price Chart Interactive Chart >

Price chart for ANGO

ANGO Price/Volume Stats

Current price $24.31 52-week high $32.00
Prev. close $24.30 52-week low $17.56
Day low $24.08 Volume 26,681
Day high $24.48 Avg. volume 269,884
50-day MA $20.92 Dividend yield N/A
200-day MA $23.08 Market Cap 947.36M

AngioDynamics, Inc. (ANGO) Company Bio


AngioDynamics designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company was founded in 1988 and is based in Latham, New York.


ANGO Latest News Stream


Event/Time News Detail
Loading, please wait...

ANGO Latest Social Stream


Loading social stream, please wait...

View Full ANGO Social Stream

Latest ANGO News From Around the Web

Below are the latest news stories about Angiodynamics Inc that investors may wish to consider to help them evaluate ANGO as an investment opportunity.

AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

LATHAM, N.Y., February 08, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference at 10:00 a.m. ET on Tuesday, February 15, 2022.

Yahoo | February 8, 2022

Riggs Asset Managment Co. Inc. Buys SPDR Gold Shares ETF, SPDR Homebuilders ETF, iShares U.S. ...

Wilkes-barre, PA, based Investment company Riggs Asset Managment Co. Inc. (Current Portfolio) buys SPDR Gold Shares ETF, SPDR Homebuilders ETF, iShares U.S.

Yahoo | February 2, 2022

Is This Small-Cap Medical Devices Stock a Buy?

AngioDynamics managed to deliver solid revenue growth in the second quarter despite COVID-19 headwinds.

Yahoo | February 1, 2022

James Clemmer Is The CEO, President & Director of AngioDynamics, Inc. (NASDAQ:ANGO) And They Just Picked Up 3.5% More Shares

Investors who take an interest in AngioDynamics, Inc. ( NASDAQ:ANGO ) should definitely note that the CEO, President...

Yahoo | January 20, 2022

Where Do Hedge Funds Stand On AngioDynamics, Inc. (ANGO)?

We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of September 30th. In this article, we look at what those funds think of AngioDynamics, Inc. (NASDAQ:ANGO) based on that data. […]

Yahoo | January 12, 2022

Read More 'ANGO' Stories Here

ANGO Price Returns

1-mo 16.20%
3-mo 30.07%
6-mo 12.70%
1-year -10.92%
3-year 27.21%
5-year 48.59%
YTD -11.86%
2021 79.91%
2020 -4.25%
2019 -20.47%
2018 21.05%
2017 -1.42%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5148 seconds.